We showed E2F3, present in the developing alveoli, upregulated at the mRNA level at P21 after LPD-induced IUGR, i.e. after downregulation at P10 of two miRNAs that are predicted to target E2F3. This evidence concerns the gene E2F3 and disseminated peritoneal leiomyomatosis.